Kymera Therapeutics KYMR
NASDAQ KYMR
$112.55 -0.91 (-0.80%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kymera Therapeutics (KYMR) Shares Repurchased (2021)

Updated

Analysis

Kymera Therapeutics (KYMR) Shares Repurchased (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 221.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 9.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 355.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Kymera Therapeutics 11.09 Bn 8.39 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 397,000.00
API Access

Kymera Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=KYMR&period=max&api_key=YOUR_API_KEY